https://www.bizjournals.com/twincities/news/2025/12/24/vyriad-raises-25-million-myeloma-treatment.html
Vyriad, startup from Mayo doctors, raises $25M for trial of multiple myeloma treatment
Vyriad, startup from Mayo doctors, raises $25M for trial of multiple myeloma treatment
Vyriad’s co-founders, Drs. Kah-Whye Peng and Stephen Russell, have remained committed to keeping the company nearby since its founding in 2016 even as potential investors have tried to convince them to relocate.
Matt Meyer
By Alyxandra Sego – Reporter, Minneapolis / St. Paul Business Journal
Updated
A Rochester biotech company founded by Mayo Clinic scientists has secured the final piece of funding it needs to begin testing a promising cancer treatment in humans. The therapy showed remarkable results in early studies.